We are live on ! Find out more
CLPT icon

ClearPoint Neuro

56 hedge funds and large institutions have $39.6M invested in ClearPoint Neuro in 2022 Q3 according to their latest regulatory filings, with 15 funds opening new positions, 18 increasing their positions, 10 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

80% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 10

67% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 9

12% more call options, than puts

Call options by funds: $2.1M | Put options by funds: $1.87M

12% more funds holding

Funds holding: 5056 (+6)

0.93% more ownership

Funds ownership: 14.69%15.62% (+0.93%)

13% less capital invested

Capital invested by funds: $45.4M → $39.6M (-$5.83M)

Holders
56
Holders Change
+6
Holders Change %
+12%
% of All Funds
0.96%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
15
Increased
18
Reduced
10
Closed
9
Calls
$2.1M
Puts
$1.87M
Net Calls
+$225K
Net Calls Change
-$1.93M

CLPT Hedge Fund Activity: Q3 2022 in Review

56 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in ClearPoint Neuro (CLPT) for Q3 2022, worth a combined $39.6M — down 13% from $45.4M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new CLPT positions and 9 closed out — a net gain of 6 holders — while 18 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $1.52M. The largest seller was Millennium Management, cutting an estimated $1.16M.

  • 56 institutional investors held ClearPoint Neuro (CLPT) as of Q3 2022, up from 50 in Q2 2022.
  • Funds reported $39.6M of ClearPoint Neuro stock for Q3 2022, down 13% quarter-over-quarter.
  • 15 funds opened new ClearPoint Neuro positions in Q3 2022 and 9 closed out, a net change of +6 holders.
  • The largest ClearPoint Neuro buyer in Q3 2022 was BlackRock, an estimated $1.52M added.
  • The largest ClearPoint Neuro seller in Q3 2022 was Millennium Management, an estimated $1.16M sold.

Based on aggregated 13F filings for Q3 2022.